financetom
Business
financetom
/
Business
/
Investment bank Oppenheimer Q3 profit falls on higher compensation expenses
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Investment bank Oppenheimer Q3 profit falls on higher compensation expenses
Oct 31, 2025 5:30 AM

Overview

* Oppenheimer Q3 2025 revenue rises 13.7% yr/yr, driven by strong investment banking

* Net income for Q3 2025 declines due to higher compensation expenses

* Adjusted EPS for Q3 2025 falls as compensation expenses rise with share price

Outlook

* Company remains optimistic about future investment opportunities amid favorable capital raising environment

* Company notes enthusiasm around AI spending as a positive market driver

* Company remains cautious about potential uncertainties in the market

Result Drivers

* INVESTMENT BANKING - Strong investment banking revenues driven by robust equity underwriting volumes amid favorable market conditions

* WEALTH MANAGEMENT - Rising markets propelled assets under management to record highs, driving higher fee-based revenues

* COMPENSATION EXPENSES - Increased compensation expenses due to stock appreciation rights tied to the rise in share price

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $424.43

Revenue mln

Q3 EPS $1.90

Q3 Net $21.71

Income mln

Q3 $31.63

Pretax mln

Profit

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved